Genmab — Juni 2018
-
dara+PD1 ser ud til at være helt stoppet - https://medwatch.dk/secure/Medicinal___Biotek/article10716909.ece
-
This is the MMY-2036 mentioned in Genmabs announcement, and according to that it was "discontinued". So when the change of recruitment status was made as late as 21. of june, it could mean that they will not recruit any more, but let the current participants continue. But not sure.
-
@E.L...I do not know about the extension both in time and patients enrolled, but the data from the study will be rather easy to comprahend by layman (press/analytics), because "..Pathologic response measured from the surgical specimen." - that means you will have the affected removed prostata in the lab. Better be good results;)
-
I forbindelse med den pris Darzalex fik i Spanien i sidste uge, udtaler den lokale Janssen direktør at 52% har CR og 1 ud af 3 MRD i kombinationsbehandling. Det må være de tal fra Pollux ? http://www.gacetamedica.com/suplementos/premios-fundamed/el-jurado-reconoce-a-darzalex-por-su-innovacion-en-el-tratamiento-del-mieloma-multiple-YD1603313
-
-
-
HuMax®-AXL-ADC Progress Triggers Milestone Payment to Seattle Genetics
Company Announcement Genmab to pay Seattle Genetics, Inc. a milestone payment of USD 7 million under the Antibody-Drug Conjugate (ADC)...
GlobeNewswire News Room (www.globenewswire.com)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind